Literature DB >> 32778248

The validation of the Helicobacter pylori CagA typing by immunohistochemistry: nationwide application in Indonesia.

Muhammad Miftahussurur1, Dalla Doohan2, Ari Fahrial Syam3, Iswan Abbas Nusi4, Langgeng Agung Waskito2, Kartika Afrida Fauzia2, Yudith Annisa Ayu Rezkitha5, Astri Dewayani6, Reny I'tishom7, Hasan Maulahela3, Tomohisa Uchida8, Yoshio Yamaoka9.   

Abstract

We aimed to validate 2 types of antibodies, anti-CagA antibody and anti-East Asian CagA specific antibody (α-EAS antibody) for the determination of CagA status in Indonesia. We also confirmed the performance of α-EAS antibody for the detection of East Asian-type CagA H. pylori. Immunohistochemistry was performed using anti-CagA antibody and α-EAS antibody on gastric biopsy specimens from a total of 967 Indonesian patients. Diagnostic values of immunohistochemistry were evaluated with PCR-based sequencing as gold standard. Anti-CagA antibody had high sensitivity, specificity, and accuracy (87.0 %, 100 %, and 98.8 %, respectively) for determining CagA status. The α-EAS antibody was not suitable for the purpose of CagA status determination, as it had a low sensitivity (23.9 %). High specificity (97.6 %) but low sensitivity (41.2 %) and accuracy (66.3 %) was observed in α-EAS antibody to detect East Asian-type CagA. Patients with positive result of immunohistochemistry using anti-CagA antibody had significantly higher monocyte infiltration score in antrum (P < 0.001) and corpus (P = 0.009). In conclusion, the anti-CagA antibody is still suitable to be used in Indonesia for determining the CagA status, whilst the α-EAS antibody was not appropriate to discriminate between East Asian-type and non-East Asian-type CagA in Indonesia.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Anti-East Asian CagA antibody; CagA typing; Immunohistochemistry; Infectious disease; anti-CagA antibody

Mesh:

Substances:

Year:  2020        PMID: 32778248      PMCID: PMC7486129          DOI: 10.1016/j.acthis.2020.151594

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  27 in total

Review 1.  The Helicobacter pylori Type IV Secretion System Encoded by the cag Pathogenicity Island: Architecture, Function, and Signaling.

Authors:  Steffen Backert; Rainer Haas; Markus Gerhard; Michael Naumann
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 2.  Mechanisms of disease: Helicobacter pylori virulence factors.

Authors:  Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

Review 3.  Carcinogenesis of Helicobacter pylori.

Authors:  Pelayo Correa; Jeanmarie Houghton
Journal:  Gastroenterology       Date:  2007-08       Impact factor: 22.682

4.  Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Akiko Fujita; Shiho Yamazaki; Masahiro Asaka; Takeshi Azuma; Masanori Hatakeyama
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

5.  Genotyping of the cagA gene of Helicobacter pylori on immunohistochemistry with East Asian CagA-specific antibody.

Authors:  Ryoko Kanada; Tomohisa Uchida; Yoshiyuki Tsukamoto; Lam Tung Nguyen; Naoki Hijiya; Keiko Matsuura; Masaaki Kodama; Tadayoshi Okimoto; Kazunari Murakami; Toshio Fujioka; Shigetaka Yanagisawa; Masatsugu Moriyama
Journal:  Pathol Int       Date:  2008-04       Impact factor: 2.534

6.  Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham; A R Sepulveda
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

7.  Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.

Authors:  Muhammad Miftahussurur; Ari Fahrial Syam; Iswan Abbas Nusi; Dadang Makmun; Langgeng Agung Waskito; Lukman Hakim Zein; Fardah Akil; Willy Brodus Uwan; David Simanjuntak; I Dewa Nyoman Wibawa; Jimmy Bradley Waleleng; Alexander Michael Joseph Saudale; Fauzi Yusuf; Syifa Mustika; Pangestu Adi; Ummi Maimunah; Hasan Maulahela; Yudith Annisa Ayu Rezkitha; Phawinee Subsomwong; Dadik Rahardjo; Rumiko Suzuki; Junko Akada; Yoshio Yamaoka
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

8.  Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence.

Authors:  Muhammad Miftahussurur; Dalla Doohan; Iswan Abbas Nusi; Pangestu Adi; Yudith Annisa Ayu Rezkitha; Langgeng Agung Waskito; Kartika Afrida Fauzia; Taufan Bramantoro; Ummi Maimunah; Husin Thamrin; Safitri Indah Masithah; Sukadiono Sukadiono; Tomohisa Uchida; Maria Inge Lusida; Yoshio Yamaoka
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

9.  Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Ari Fahrial Syam; Iswan Abbas Nusi; Gontar Siregar; Marselino Richardo; Achmad Fuad Bakry; Yudith Annisa Ayu Rezkitha; I Dewa Nyoman Wibawa; Yoshio Yamaoka
Journal:  Infect Drug Resist       Date:  2019-01-31       Impact factor: 4.003

10.  Rare Helicobacter pylori Virulence Genotypes in Bhutan.

Authors:  Osamu Matsunari; Muhammad Miftahussurur; Seiji Shiota; Rumiko Suzuki; Ratha-Korn Vilaichone; Tomohisa Uchida; Thawee Ratanachu-ek; Lotay Tshering; Varocha Mahachai; Yoshio Yamaoka
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.